CTCBIO Inc. (KOSDAQ:060590)
3,705.00
-190.00 (-4.88%)
At close: Apr 2, 2026
CTCBIO Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 16,751 | 19,171 | 24,629 | 23,953 | 7,415 |
Short-Term Investments | 960 | - | 50 | 398 | 280 |
Cash & Short-Term Investments | 17,711 | 19,171 | 24,679 | 24,351 | 7,695 |
Cash Growth | -7.62% | -22.32% | 1.35% | 216.45% | -47.57% |
Accounts Receivable | 19,708 | 20,089 | 24,158 | 26,899 | 30,541 |
Other Receivables | 556.03 | 307.05 | 155.26 | 205.28 | 404.06 |
Receivables | 20,264 | 21,696 | 24,314 | 27,805 | 31,945 |
Inventory | 30,414 | 30,685 | 32,776 | 35,891 | 29,664 |
Prepaid Expenses | 113.59 | 383.87 | 489.31 | 687.21 | 241.15 |
Other Current Assets | 968.7 | 1,602 | 1,860 | 1,102 | 1,148 |
Total Current Assets | 69,470 | 73,539 | 84,119 | 89,836 | 70,694 |
Property, Plant & Equipment | 56,545 | 60,895 | 62,081 | 74,992 | 78,965 |
Long-Term Investments | 1,483 | 1,516 | 1,124 | 3,569 | 5,988 |
Other Intangible Assets | 1,283 | 1,050 | 1,078 | 1,293 | 1,711 |
Long-Term Accounts Receivable | 0 | 0 | 0 | 0 | 0 |
Long-Term Deferred Tax Assets | 6,997 | 6,674 | 6,427 | 5,344 | - |
Long-Term Deferred Charges | 6,811 | 8,918 | 10,186 | 10,501 | 10,184 |
Other Long-Term Assets | 647.57 | 1,097 | 846.62 | 792.76 | 684.79 |
Total Assets | 143,235 | 153,688 | 165,862 | 186,326 | 168,226 |
Accounts Payable | 4,932 | 6,315 | 6,644 | 4,736 | 6,721 |
Accrued Expenses | 7,823 | 19,866 | 9,670 | 9,940 | 6,051 |
Short-Term Debt | 26,500 | 27,550 | 29,012 | 30,934 | 28,432 |
Current Portion of Long-Term Debt | - | 578.54 | 1,500 | 1,171 | 1,171 |
Current Portion of Leases | 818.42 | 1,223 | 1,001 | 1,070 | 801.18 |
Current Income Taxes Payable | - | 3.79 | 34.94 | 905.01 | 214.84 |
Other Current Liabilities | 6,038 | 6,876 | 15,448 | 15,105 | 10,007 |
Total Current Liabilities | 46,111 | 62,412 | 63,310 | 63,862 | 53,398 |
Long-Term Debt | 9,200 | - | 578.54 | 1,750 | 7,748 |
Long-Term Leases | 2,225 | 3,518 | 3,198 | 5,033 | 2,504 |
Pension & Post-Retirement Benefits | 8,304 | 10,014 | 8,187 | 7,038 | 6,811 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 793.09 |
Other Long-Term Liabilities | 361.98 | 4,350 | 4,138 | 3,944 | 5,201 |
Total Liabilities | 66,202 | 80,294 | 79,412 | 81,627 | 76,455 |
Common Stock | 12,091 | 12,091 | 12,091 | 12,091 | 11,812 |
Additional Paid-In Capital | 120,863 | 120,863 | 120,863 | 120,863 | 116,726 |
Retained Earnings | -52,275 | -55,388 | -49,284 | -33,474 | -39,107 |
Treasury Stock | -4,887 | -4,887 | -4,887 | -4,887 | -4,887 |
Comprehensive Income & Other | -3,067 | -3,058 | -3,338 | -689.24 | 468.61 |
Total Common Equity | 72,724 | 69,620 | 75,444 | 93,903 | 85,013 |
Shareholders' Equity | 77,033 | 73,395 | 86,450 | 104,699 | 91,771 |
Total Liabilities & Equity | 143,235 | 153,688 | 165,862 | 186,326 | 168,226 |
Total Debt | 38,743 | 32,870 | 35,289 | 39,958 | 40,656 |
Net Cash (Debt) | -21,032 | -13,698 | -10,610 | -15,607 | -32,961 |
Net Cash Per Share | -882.70 | -572.03 | -443.76 | -655.27 | -1483.12 |
Filing Date Shares Outstanding | 23.58 | 23.91 | 23.91 | 23.91 | 23.35 |
Total Common Shares Outstanding | 23.58 | 23.91 | 23.91 | 23.91 | 23.35 |
Working Capital | 23,359 | 11,127 | 20,808 | 25,974 | 17,296 |
Book Value Per Share | 3083.77 | 2911.92 | 3155.51 | 3927.55 | 3640.60 |
Tangible Book Value | 71,441 | 68,570 | 74,366 | 92,610 | 83,302 |
Tangible Book Value Per Share | 3029.38 | 2867.99 | 3110.43 | 3873.48 | 3567.33 |
Land | 14,867 | 14,867 | 14,867 | 14,867 | 14,867 |
Buildings | 46,297 | 46,297 | 46,302 | 47,331 | 49,123 |
Machinery | 35,775 | 36,220 | 34,743 | 38,493 | 37,611 |
Construction In Progress | 181.62 | 268.05 | 375.67 | 2,206 | 3,891 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.